| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 9,437,400 | 8,320,713 | ||
| Marketable securities | 17,856,688 | 25,210,453 | ||
| Prepaid expenses and other current assets | 1,685,972 | 1,964,327 | ||
| Deferred offering costs | 269,331 | 224,931 | ||
| Grant receivable | 1,361,387 | 2,360,975 | ||
| Total current assets | 30,610,778 | 38,081,399 | ||
| Total assets | 30,610,778 | 38,081,399 | ||
| Accounts payable | 1,349,219 | 1,845,609 | ||
| Accrued expenses and other current liabilities | 3,250,095 | 2,796,011 | ||
| Total liabilities | 4,599,314 | 4,641,620 | ||
| Common stock, 0.001 par value 1,000,000,000 shares authorized at september 30, 2025 and december 31, 2024 9,252,719 and 8,702,719 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 9,252 | 9,252 | ||
| Additional paid-in capital | 115,606,949 | 115,315,232 | ||
| Accumulated other comprehensive income | 5,824 | -783 | ||
| Accumulated deficit | -89,610,561 | -81,883,922 | ||
| Total stockholders' equity | 26,011,464 | 33,439,779 | ||
| Total liabilities and stockholders' equity | 30,610,778 | 38,081,399 | ||
CervoMed Inc. (CRVO)
CervoMed Inc. (CRVO)